Wealth Enhancement Advisory Services, LLC Immunome Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Immunome Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 17,660 shares of IMNM stock, worth $302,692. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,660
Previous 53,187
66.8%
Holding current value
$302,692
Previous $494,000
58.7%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IMNM
# of Institutions
167Shares Held
71.5MCall Options Held
325KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.42MShares$144 Million0.06% of portfolio
-
Redmile Group, LLC San Francisco, CA5.02MShares$86.1 Million6.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$83.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.82MShares$82.7 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$69.9 Million3.55% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $208M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...